SCHEMBL9838569

SCHEMBL9838569

CN1C(=O)C(Sc2ccccc2)c2cccnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.41
RIPK1 Q13546 8/20 0.37
MYC P01106 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
TSHR P16473 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A2 P05177 1/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CYP2D6 P10635 1/20 0.33
CHRM1 P11229 1/20 0.33
CYP2C9 P11712 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
DRD1 P21728 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9470397 0.83 ADRA2A (0.37) SRCALDH1A1CYP1A2ADRA2ACYP2D6
SCHEMBL9470388 0.82 TSHR (0.37) SRCMYCTSHRALDH1A1CCNA2
SCHEMBL9470368 0.82 ALDH1A1 (0.43) ALDH1A1
SCHEMBL9469978 0.79 LMNA (0.40) TSHRALDH1A1
SCHEMBL4690229 0.77 ALDH1A1 (0.34) ALDH1A1ADRA2A
SCHEMBL9469385 0.77 GAA (0.39) ALDH1A1CYP2D6CYP2C19
SCHEMBL9470466 0.76 KMT2A (0.47) TSHRALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL9470341 0.75 MEN1 (0.40) ALDH1A1
SCHEMBL9469283 0.75 ALDH1A1 (0.39) TSHRALDH1A1CYP1A2CYP2C19
SCHEMBL9470503 0.74 ALDH1A1 (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0419561-A1 HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY SCHERING CORPORATION (US) 1991-04-03 EP claimed
WO-1989012637-A1 HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY SCHERING CORPORATION (US) 1989-12-28 WO claimed
EP-0419561-A1 HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY SCHERING CORPORATION (US) 1991-04-03 EP disclosed
WO-1989012637-A1 HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY SCHERING CORPORATION (US) 1989-12-28 WO disclosed